11:19 EDT Dyne Therapeutics (DYN) trading halted, volatility trading pause
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DYN:
- Dyne Therapeutics price target lowered to $13 from $34 at Oppenheimer
- Dyne Therapeutics: Promising Advancements and FDA Support Drive Buy Rating
- Dyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251
- Dyne Therapeutics announces FDA BTD to DYNE-251
- Dyne Therapeutics: Strategic Advancements and Financial Stability Drive Buy Rating